Abstract
Coronavirus disease-2019, a viral disease caused by the novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), was identified by the Centre for Disease Control (CDC), China, on January 7, 2020. This mysterious respiratory epidemic occurred in Wuhan, China, in late December 2019. A month after its outbreak in China, the World Health Organization (WHO) declared it as a public health emergency of international concern (PHEIC) due to its severity and high transmission potential throughout the world, leading many nations to implement multiple lockdown sessions and strict social distancing measures. As of September 21, 2020, 30,675,675 active cases and 954,417 deaths had been reported worldwide. Intensive research is being carried out across the globe to identify precise diagnostic techniques and develop novel, effective vaccines against the virus. Herein, we elaborate on details of epidemiology, genetics, pathophysiology, diagnosis, prevention, and vaccine trials related to this pandemic.
Keywords: COVID-19, global outbreak, novel coronavirus, pathogenesis, SARS-CoV-2, vaccines.
Coronaviruses
Title:2019 Novel Coronavirus: A Review on Epidemiology, Pathophysiology, Diagnosis and Current Clinical Trials in Vaccine Development
Volume: 2 Issue: 8
Author(s): Megala Jayaraman*, Sabari Krishna B. B., Parijat Dutta, Jayesh Telang, Sreshta Adhikari and Arpan Neeraj Pardeshi
Affiliation:
- Department of Genetic Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur-603203, Chennai, Tamil Nadu,India
Keywords: COVID-19, global outbreak, novel coronavirus, pathogenesis, SARS-CoV-2, vaccines.
Abstract: Coronavirus disease-2019, a viral disease caused by the novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), was identified by the Centre for Disease Control (CDC), China, on January 7, 2020. This mysterious respiratory epidemic occurred in Wuhan, China, in late December 2019. A month after its outbreak in China, the World Health Organization (WHO) declared it as a public health emergency of international concern (PHEIC) due to its severity and high transmission potential throughout the world, leading many nations to implement multiple lockdown sessions and strict social distancing measures. As of September 21, 2020, 30,675,675 active cases and 954,417 deaths had been reported worldwide. Intensive research is being carried out across the globe to identify precise diagnostic techniques and develop novel, effective vaccines against the virus. Herein, we elaborate on details of epidemiology, genetics, pathophysiology, diagnosis, prevention, and vaccine trials related to this pandemic.
Export Options
About this article
Cite this article as:
Jayaraman Megala *, B. B. Krishna Sabari , Dutta Parijat , Telang Jayesh , Adhikari Sreshta and Pardeshi Neeraj Arpan , 2019 Novel Coronavirus: A Review on Epidemiology, Pathophysiology, Diagnosis and Current Clinical Trials in Vaccine Development, Coronaviruses 2021; 2 (8) : e260721189629 . https://dx.doi.org/10.2174/2666796701666201230104321
DOI https://dx.doi.org/10.2174/2666796701666201230104321 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of mRAGEs and ACE2 in SARS-CoV-2-Related Inflammation
Recent Advances in Inflammation & Allergy Drug Discovery A Concept of Homeostatic Inflammation Provided by Endogenous TLR4 Agonists that Function Before and After Danger Signal for Metastasis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Development of Peptide Drugs and Advance on Theory and Methodology of Peptide Inhibitor Design
Medicinal Chemistry The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors
Mini-Reviews in Medicinal Chemistry Hydroxamic Acids as Pharmacological Agents: An Update
Medicinal Chemistry Reviews - Online (Discontinued) Synthesis and Antitumour Activity of the Primin (2-methoxy-6-n-pentyl-1,4-benzoquinone) and Analogues
Medicinal Chemistry Pharmacophore-Based Discovery of New Human Dihydroorotate Dehydrogenase Inhibitor
Medicinal Chemistry Organoid Models of Heart Diseases: Find a New Channel in Improvements of Cardiac Regenerative Medicine
Current Medicinal Chemistry Synthesis of 4-Phenylthieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidine-5(4H)-one Derivatives and Evaluation of Their Anti-inflammatory Activity
Letters in Drug Design & Discovery Bioactive Compounds from Medicinal Plants and their Possible Effect as Therapeutic Agents against COVID-19: A Review
Current Nutrition & Food Science Diagnosis and Possible Use of Traditional Medicinal Plant to combat COVID-19
Coronaviruses Recent Medicinal Chemistry Studies for Multitarget Agents-Part I
Current Drug Targets Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
Current Topics in Medicinal Chemistry Antiviral Drug Discovery and Development for Mayaro Fever – What do we have so far?
Mini-Reviews in Medicinal Chemistry Aminoquinoline Melanin-Concentrating Hormone 1-Receptor (MCH1-R) Antagonists
Current Topics in Medicinal Chemistry Proteomic Analysis of Neutrophil Priming by PAF
Protein & Peptide Letters Editorial [Exogenous Surfactant for Pediatric Acute Lung Injury: Who, when and how?]
Current Respiratory Medicine Reviews The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment
Current Neurovascular Research Click Reactions in Chemistry of Triterpenes - Advances Towards Development of Potential Therapeutics
Current Medicinal Chemistry An Efficient Synthesis and Antiviral Activity Evaluation of 1-[4-(5-Phenyl- 4, 5 dihydro-1H-pyrazole [& (4, 5 dihydroisoxazole)]-3-yl)-phenyl]-pyrrole- 2, 5-dione Derivates
Anti-Infective Agents